Table S7 from Glecirasib, a Potent and Selective Covalent KRAS G12C Inhibitor Exhibiting Synergism with Cetuximab or SHP2 Inhibitor JAB-3312

2026 Open access

Read full text
Authors: Peng George Wang, Xin Sun, Xueting He, Di Kang, Xiaoyu Liu, Dan Liu, Amin Li, Guiqun Yang, Yiwei Lin, Sujing Li, Yinxiang Wang, Yanping Wang
DOI: 10.1158/2767-9764.31761859
Cited by: 0

Abstract

Table S7 shows IC50 values in p-ERK inhibition assays and cell viability assays.

Fields of Study & Subjects

Melanoma and MAPK Pathways Protein Kinase Regulation and GTPase Signaling Protein Tyrosine Phosphatases

Publication details

Publication date
16 March 2026
Language
EN